For more than 100 years, Hadassah Medical Organization has combined outstanding patient care with pioneering medical research, translating scientific excellence into advances that improve lives and make a global impact. Every day, its doctors and scientists work together to turn new discoveries into better treatments for patients facing some of medicine’s greatest challenges.

One of those challenges is cancer.

Today, through the Hadassah Cancer Research Institute, Hadassah is helping transform the future of cancer care. By bringing together leading clinicians, scientists and innovative technologies, its researchers are developing more personalised treatments and giving patients renewed hope.

Hadassah UK warmly welcomes Professor Michal Lotem, Director of the Hadassah Cancer Research Institute, to London this November.

Professor Lotem will explore the scientific advances driving the future of cancer care and improving patient outcomes.

To register your interest in our events with Professor Lotem, please COMPLETE THIS SHORT FORM

‘‘My dream is to develop therapies that harness the body’s immune system to overcome cancer. Every discovery brings us closer to making that possible.”

Professor Michal Lotem, MD
Founder & Director, Hadassah Cancer Research Institute
Head, Centre for Melanoma and Cancer Immunotherapy